Considerable heterogeneity was observed among JMML patients, and both PCA and clustering (Figure 1B) showed that KRAS, NRAS, and PTPN11 mutated patients clustered together, while the two NF1 samples clearly separated from both HD and the other molecular groups. This evidence concerns the gene PTPN11 and Huntington disease.